James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 19,564 shares at $3.15 ($64K) on 2025-02-10, disclosed to the SEC on 2025-02-11.
Seasonal sale ($64k) by CEO, President and Director — this insider has traded CKPT in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.41 | 9,233 | $31K | 49.2% |
| 2 | $3.15 | 10,331 | $33K | 50.8% |
| Total | $3.27 avg | 19,564 | $64K | 100% |
| Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |
| CKPT | SELL | 2024-02-02 | $24K | — | Filing → |